compartir en facebook Compartir en Twitter compartir en Linkedin

Diabetes, Obesidad y Nutrición

Grupo Diabetes

Usted está aquí

Publicaciones

Existe un listado anual de referencias de publicaciones del grupo en el apartado Memorias

Algoritmo de manejo de la diabetes tipo 2 versión 2022

-Algoritmo completo, aquí.

Obesity is a chronic disease. Positioning statement of the Diabetes, Obesity and Nutrition Workgroup of the Spanish Society of Internal Medicine (SEMI) for an approach centred on individuals with obesity

Introduction: Obesity is a chronic, complex and multifactorial metabolic disease involved in the development of chronic noncommunicable diseases such as type 2 diabetes mellitus, cardiovascular disease and cancer. The care of individuals with obesity is an essential part of the holistic approach provided by internal medicine to patients.

Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination

La infección por SARS-CoV-2 se relaciona con un riesgo alto de malnutrición, principalmente por el aumento de los requerimientos nutricionales y la presencia de un estado inflamatorio severo y universal. Los síntomas asociados contribuyen a la hiporexia, que perpetúa el balance nutricional negativo. Además, la disfagia, especialmente posintubación, empeora y hace poco segura la ingesta. Este riesgo es mayor en pacientes ancianos y multimórbidos.

Publicaciones GT Diabetes 2020

Carretero Gómez J, Mafé Nogueroles MC, Garrachón Vallo F, Escudero Álvarez E, Maciá Botejara E, Miramontes González JP; en representación del grupo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna (SEMI).. [Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination]. Rev Clin Esp. 2020 Nov;220(8):511-517. doi: 10.1016/j.rce.2020.07.007. Epub 2020 Aug 24. Spanish.

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Background: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination with metformin in patients with type 2 diabetes mellitus admitted for COVID-19.

Admission hyperglycemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: Data from the Spanish SEMI-COVID-19 Registry

Background: Hyperglycaemia has emerged as an important risk factor for death in coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the association between blood glucose (BG) levels and in-hospital mortality in non-critically patients hospitalized with COVID-19.

Novedades y controversias en diabetes mellitus tipo 2

Coordinador: Ricardo Gómez Huelgas

Libro de casos clínicos de la VII Reunión Diabetes y Obesidad

Guardiaapp